T cell-derived inducible nitric oxide synthase switches offth17 cell differentiation

Journal of Experimental Medicine

Volumn 210, Issue 7, 2013, Pages 1447-1462

  Yang, Jianjun ^a   Zhang, Ruihua ^a   Lu, Geming ^a   Shen, Yu ^a   Peng, Liang ^a   Zhu, Chen ^b   Cui, Miao ^a   Wang, Weidong ^c   Arnaboldi, Paul ^a   Tang, Meng ^d   Gupta, Monica ^e   Qi, Chen Feng ^e   Jayaraman, Padmini ^a   Zhu, Hongfa ^a   Jiang, Bo ^a   Chen, Shu hsia ^a   He, John Cijiang ^a   Ting, Adrian T ^a   Zhou, Ming Ming ^a   Kuchroo, Vijay K ^b   Morse III, Herbert C ^e   Ozato, Keiko ^e   Sikora, Andrew G ^a   Xiong, Huabao ^a   more..

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d SOUTHEAST UNIVERSITY   (China)

^e EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; N ACETYL S NITROSOPENICILLAMINE; N6 (1 IMINOETHYL)LYSINE; NEURONAL NITRIC OXIDE SYNTHASE; RETINOID RELATED ORPHAN RECEPTOR GAMMA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; COLITIS; CONTROLLED STUDY; ENZYME DEFICIENCY; GENETIC TRANSCRIPTION; INFLAMMATION; MOLECULAR MECHANICS; MOUSE; MOUSE MUTANT; NITRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH17 CELL;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; COLITIS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; TH17 CELLS;

EID: 84880662741     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20122494     Document Type: Article

References (51)

1. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T.B. Strom, M. Oukka, H.L. Weiner, and V.K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 441:235-238. http://dx.doi.org/10.1038/nature04753
2. Bettelli, E., T. Korn, and V.K. Kuchroo. 2007. Th17: the third member of the effector T cell trilogy. Curr. Opin. Immunol. 19:652-657. http://dx.doi.org/10.1016/j.coi.2007.07.020
3. Bogdan, C. 1998. The multiplex function of nitric oxide in (auto)immunity. J. Exp. Med. 187:1361-1365. http://dx.doi.org/10.1084/jem.187.9.1361
4. Bogdan, C. 2001. Nitric oxide and the immune response. Nat. Immunol. 2:907-916. http://dx.doi.org/10.1038/ni1001-907
5. Bogdan, C., M. Röllinghoff, and A. Diefenbach. 2000. The role of nitric oxide in innate immunity. Immunol. Rev. 173:17-26. http://dx.doi.org/10.1034/j.1600-065X.2000.917307.x
6. Calabrese, V., C. Mancuso, M. Calvani, E. Rizzarelli, D.A. Butterfield, and A.M. Stella. 2007. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat. Rev. Neurosci. 8:766-775. http://dx.doi.org/10.1038/nrn2214
7. Fenyk-Melody, J.E., A.E. Garrison, S.R. Brunnert, J.R. Weidner, F. Shen, B.A. Shelton, and J.S. Mudgett. 1998. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J. Immunol. 160:2940-2946.
8. Giordano, D., C. Li, M.S. Suthar, K.E. Draves, D.Y. Ma, M. Gale Jr., and E.A. Clark. 2011. Nitric oxide controls an inflammatory-like Ly6C(hi)PDCA1+ DC subset that regulates Th1 immune responses. J. Leukoc. Biol. 89:443-455. http://dx.doi.org/10.1189/jlb.0610329
9. Griffith, O.W., and D.J. Stuehr. 1995. Nitric oxide synthases: properties and catalytic mechanism. Annu. Rev. Physiol. 57:707-736. http://dx.doi.org/10.1146/annurev.ph.57.030195.003423
10. Gu, Y., J. Yang, X. Ouyang, W. Liu, H. Li, J. Yang, J. Bromberg, S.H. Chen, L. Mayer, J.C. Unkeless, and H. Xiong. 2008. Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells. Eur. J. Immunol. 38:1807-1813. http://dx.doi.org/10.1002/eji.200838331
11. Harrington, L.E., R.D. Hatton, P.R. Mangan, H. Turner, T.L. Murphy, K.M. Murphy, and C.T. Weaver. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6:1123-1132. http://dx.doi.org/10.1038/ni1254
12. Huang, F.P., W. Niedbala, X.Q. Wei, D. Xu, G.J. Feng, J.H. Robinson, C. Lam, and F.Y. Liew. 1998. Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. Eur. J. Immunol. 28:4062-4070. http://dx.doi.org/10.1002/(SICI)1521-4141(199812)28:12<4062::AID-IMMU4062>3.0.CO;2-K
13. Ibiza, S., V.M. Víctor, I. Boscá, A. Ortega, A. Urzainqui, J.E. O'Connor, F. Sánchez-Madrid, J.V. Esplugues, and J.M. Serrador. 2006. Endothelial nitric oxide synthase regulates T cell receptor signaling at the immunological synapse. Immunity. 24:753-765. http://dx.doi.org/10.1016/j.immuni.2006.04.006
14. Ischiropoulos, H., and A. Gow. 2005. Pathophysiological functions of nitric oxide-mediated protein modifications. Toxicology. 208:299-303. http://dx.doi.org/10.1016/j.tox.2004.11.018
15. Ivanov, I.I., B.S. McKenzie, L. Zhou, C.E. Tadokoro, A. Lepelley, J.J. Lafaille, D.J. Cua, and D.R. Littman. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 126:1121-1133. http://dx.doi.org/10.1016/j.cell.2006.07.035
16. Jackson, S.H., S. Devadas, J. Kwon, L.A. Pinto, and M.S. Williams. 2004. T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat. Immunol. 5:818-827. http://dx.doi.org/10.1038/ni1096
17. Ji, Y., I. Neverova, J.E. Van Eyk, and B.M. Bennett. 2006. Nitration of tyrosine 92 mediates the activation of rat microsomal glutathione s-transferase by peroxynitrite. J. Biol. Chem. 281:1986-1991. http://dx.doi.org/10.1074/jbc. M509480200
18. Khan, M., B. Sekhon, S. Giri, M. Jatana, A.G. Gilg, K. Ayasolla, C. Elango, A.K. Singh, and I. Singh. 2005. S-Nitrosoglutathione reduces inflammation and protects brain against focal cerebral ischemia in a rat model of experimental stroke. J. Cereb. Blood Flow Metab. 25:177-192. http://dx.doi.org/10.1038/sj.jcbfm.9600012
19. Khan, M., M. Jatana, C. Elango, A.S. Paintlia, A.K. Singh, and I. Singh. 2006. Cerebrovascular protection by various nitric oxide donors in rats after experimental stroke. Nitric Oxide. 15:114-124. http://dx.doi.org/10.1016/j.niox.2006.01.008
20. Korn, T., E. Bettelli, W. Gao, A. Awasthi, A. Jäger, T.B. Strom, M. Oukka, and V.K. Kuchroo. 2007. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature. 448:484-487. http://dx.doi.org/10.1038/nature05970
21. Korn, T., E. Bettelli, M. Oukka, and V.K. Kuchroo. 2009. IL-17 and Th17 Cells. Annu. Rev. Immunol. 27:485-517. http://dx.doi.org/10.1146/annurev.immunol.021908.132710
22. Lee, S.W., H. Choi, S.Y. Eun, S. Fukuyama, and M. Croft. 2011. Nitric oxide modulates TGF-beta-directive signals to suppress Foxp3+ regulatory T cell differentiation and potentiate Th1 development. J. Immunol. 186: 6972-6980. http://dx.doi.org/10.4049/jimmunol.1100485
23. Liang, S.C., X.Y. Tan, D.P. Luxenberg, R. Karim, K. Dunussi-Joannopoulos, M. Collins, and L.A. Fouser. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203:2271-2279. http://dx.doi.org/10.1084/jem.20061308
24. Mangan, P.R., L.E. Harrington, D.B. O'Quinn, W.S. Helms, D.C. Bullard, C.O. Elson, R.D. Hatton, S.M. Wahl, T.R. Schoeb, and C.T. Weaver. 2006. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature. 441:231-234. http://dx.doi.org/10.1038/nature04754
25. McGeachy, M.J., Y. Chen, C.M. Tato, A. Laurence, B. Joyce-Shaikh, W.M. Blumenschein, T.K. McClanahan, J.J. O'Shea, and D.J. Cua. 2009. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat. Immunol. 10:314-324. http://dx.doi.org/10.1038/ni.1698
26. Moncada, S., R.M. Palmer, and E.A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142.
27. Nath, N., O. Morinaga, and I. Singh. 2010. S-nitrosoglutathione a physiologic nitric oxide carrier attenuates experimental autoimmune encephalomyelitis. J. Neuroimmune Pharmacol. 5:240-251. http://dx.doi.org/10.1007/s11481-009-9187-x
28. Niedbala, W., B. Cai, and F.Y. Liew. 2006. Role of nitric oxide in the regulation of T cell functions. Ann. Rheum. Dis. 65:iii37-iii40. http://dx.doi.org/10.1136/ard.2006.058446
29. Niedbala, W., J.C. Alves-Filho, S.Y. Fukada, S.M. Vieira, A. Mitani, F. Sonego, A. Mirchandani, D.C. Nascimento, F.Q. Cunha, and F.Y. Liew. 2011. Regulation of type 17 helper T-cell function by nitric oxide during inflammation. Proc. Natl. Acad. Sci. USA. 108:9220-9225. http://dx.doi.org/10.1073/pnas.1100667108
30. Nurieva, R., X.O. Yang, G. Martinez, Y. Zhang, A.D. Panopoulos, L. Ma, K. Schluns, Q. Tian, S.S. Watowich, A.M. Jetten, and C. Dong. 2007. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature. 448:480-483. http://dx.doi.org/10.1038/nature05969
31. Okuda, Y., S. Sakoda, H. Fujimura, and T. Yanagihara. 1997. Nitric oxide via an inducible isoform of nitric oxide synthase is a possible factor to eliminate inflammatory cells from the central nervous system of mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 73:107-116. http://dx.doi.org/10.1016/S0165-5728(96)00194-4
32. Ouyang, X., R. Zhang, J. Yang, Q. Li, L. Qin, C. Zhu, J. Liu, H. Ning, M.S. Shin, M. Gupta, et al. 2011. Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation. Nat Commun. 2:314. http://dx.doi.org/10.1038/ncomms1311
33. Pannu, R., and I. Singh. 2006. Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms. Neurochem. Int. 49:170-182. http://dx.doi.org/10.1016/j.neuint.2006.04.010
34. Powrie, F., M.W. Leach, S. Mauze, L.B. Caddle, and R.L. Coffman. 1993. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int. Immunol. 5:1461-1471. http://dx.doi.org/10.1093/intimm/5.11.1461
35. Prasad, R., S. Giri, N. Nath, I. Singh, and A.K. Singh. 2007. GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial- monocyte interactions. Glia. 55:65-77. http://dx.doi.org/10.1002/glia.20436
36. Radi, R. 2004. Nitric oxide, oxidants, and protein tyrosine nitration. Proc. Natl. Acad. Sci. USA. 101:4003-4008. http://dx.doi.org/10.1073/pnas.0307446101
37. Stumhofer, J.S., A. Laurence, E.H. Wilson, E. Huang, C.M. Tato, L.M. Johnson, A.V. Villarino, Q. Huang, A. Yoshimura, D. Sehy, et al. 2006. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7:937-945. http://dx.doi.org/10.1038/ni1376
38. Thüring, H., S. Stenger, D. Gmehling, M. Röllinghoff, and C. Bogdan. 1995. Lack of inducible nitric oxide synthase activity in T cell clones and T lymphocytes from naive and Leishmania major-infected mice. Eur. J. Immunol. 25:3229-3234. http://dx.doi.org/10.1002/eji.1830251205
39. Totsuka, T., T. Kanai, Y. Nemoto, S. Makita, R. Okamoto, K. Tsuchiya, and M. Watanabe. 2007. IL-7 Is essential for the development and the persistence of chronic colitis. J. Immunol. 178:4737-4748.
40. Veldhoen, M., R.J. Hocking, C.J. Atkins, R.M. Locksley, and B. Stockinger. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 24:179-189. http://dx.doi.org/10.1016/j.immuni.2006.01.001
41. Vig, M., S. Srivastava, U. Kandpal, H. Sade, V. Lewis, A. Sarin, A. George, V. Bal, J.M. Durdik, and S. Rath. 2004. Inducible nitric oxide synthase in T cells regulates T cell death and immune memory. J. Clin. Invest. 113:1734-1742.
42. Weaver, C.T., L.E. Harrington, P.R. Mangan, M. Gavrieli, and K.M. Murphy. 2006. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity. 24:677-688. http://dx.doi.org/10.1016/j.immuni.2006.06.002
43. Wilke, C.M., K. Bishop, D. Fox, and W. Zou. 2011. Deciphering the role of Th17 cells in human disease. Trends Immunol. 32:603-611. http://dx.doi.org/10.1016/j.it.2011.08.003
44. Williams, M.S., S. Noguchi, P.A. Henkart, and Y. Osawa. 1998. Nitric oxide synthase plays a signaling role in TCR-triggered apoptotic death. J. Immunol. 161:6526-6531.
45. Xiong, H., I. Kawamura, T. Nishibori, and M. Mitsuyama. 1996. Suppression of IFN-gamma production from Listeria monocytogenes-specific T cells by endogenously produced nitric oxide. Cell. Immunol. 172:118-125. http://dx.doi.org/10.1006/cimm.1996.0222
46. Xiong, H., C. Zhu, F. Li, R. Hegazi, K. He, M. Babyatsky, A.J. Bauer, and S.E. Plevy. 2004. Inhibition of interleukin-12 p40 transcription and NFkappaB activation by nitric oxide in murine macrophages and dendritic cells. J. Biol. Chem. 279:10776-10783. http://dx.doi.org/10.1074/jbc. M313416200
47. Yakovlev, V.A., I.J. Barani, C.S. Rabender, S.M. Black, J.K. Leach, P.R. Graves, G.E. Kellogg, and R.B. Mikkelsen. 2007. Tyrosine nitration of IkappaBalpha: a novel mechanism for NF-kappaB activation. Biochemistry. 46:11671-11683. http://dx.doi.org/10.1021/bi701107z
48. Yang, L., D.E. Anderson, C. Baecher-Allan, W.D. Hastings, E. Bettelli, M. Oukka, V.K. Kuchroo, and D.A. Hafler. 2008. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature. 454:350-352. http://dx.doi.org/10.1038/nature07021
49. Zheng, Y., D.M. Danilenko, P. Valdez, I. Kasman, J. Eastham-Anderson, J. Wu, and W. Ouyang. 2007. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 445:648-651. http://dx.doi.org/10.1038/nature05505
50. Zhou, L., I.I. Ivanov, R. Spolski, R. Min, K. Shenderov, T. Egawa, D.E. Levy, W.J. Leonard, and D.R. Littman. 2007. IL-6 programs T(H)- 17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8:967-974. http://dx.doi.org/10.1038/ni1488
51. Zielasek, J., S. Jung, R. Gold, F.Y. Liew, K.V. Toyka, and H.P. Hartung. 1995. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis. J. Neuroimmunol. 58:81-88. http://dx.doi.org/10.1016/0165-5728(94) 00192-